Filer reports proposed sale of MDT common stock

Filer reports proposed sale of Common stock via Form 144.

Rhea-AI Filing Summary

Filer reports proposed sale of Common stock via Form 144. The filing lists proposed dispositions of Common shares tied to restricted stock vesting and option exercises with transaction dates including 12/06/2025 and filing date 02/19/2026. Examples shown include Fidelity Brokerage Services LLC 52,524 and an individual grant-related lot of 30,568 shares.

Insights

Securities Counsel

Form 144 shows proposed brokered resale of equity tied to compensation and option exercises.

The filing lists multiple blocks of Common stock linked to restricted stock vesting and option grants dated 07/31/2023, 07/29/2024, and 08/01/2022. Timing in the excerpt centers on 12/06/2025 and the filing date 02/19/2026.

Cash‑flow treatment and aggregate offering totals are not stated in the excerpt; subsequent sale activity will depend on broker execution and applicable resale restrictions. Future filings may report completed transactions and exact proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MDT Form 144 filing disclose?

The filing discloses proposed sales of Common stock tied to restricted stock vesting and option exercises. It lists transaction dates including 12/06/2025 and the filing date 02/19/2026, plus per‑lot share examples.

Who is listed as a selling holder in the MDT excerpt?

The excerpt lists Fidelity Brokerage Services LLC as a selling broker with an example amount of 52,524 shares. Other listed lots include option/grant‑related quantities such as 30,568 shares.

Are proceeds to the company reported in the MDT Form 144?

No proceeds recipient is stated in the provided excerpt. The entries reference brokered resale and grant sources but do not identify whether proceeds go to the issuer or selling holders.

Does the MDT filing show completed sales or only proposed transactions?

The excerpt shows proposed securities to be sold and filing details for 02/19/2026. It does not show completed sale confirmations or final proceeds; subsequent filings may disclose execution.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 03:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001708062
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Medtronic plc
SEC File Number	001-36820
Address of Issuer	BUILDING TWO PARKMORE BUSINESS PARK WEST GALWAY IRELAND H91 4K49
Phone	01135314381700
Name of Person for Whose Account the Securities are To Be Sold	KIIL HARRY SKIP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	52524	5132217.35	1282014208	02/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/06/2025	Restricted Stock Vesting	Issuer			1648	12/06/2025	Compensation
Common	02/19/2026	Option Granted 07/31/2023	Issuer			19923	02/19/2026	Cash
Common	02/19/2026	Option Granted 07/29/2024	Issuer			385	02/19/2026	Cash
Common	02/19/2026	Option Granted 08/01/2022	issuer			30568	02/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Harry Kiil
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)